Business Description
MEDITERA TIBBI MALZEME SANAYI VE TICARET AS
ISIN : TREMDTR00028
Description
Financial Strength
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 4.86 | |||||
Equity-to-Asset | 0.76 | |||||
Debt-to-Equity | 0.04 | |||||
Debt-to-EBITDA | 0.4 | |||||
Interest Coverage | 5.09 | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | 7.12 | |||||
Beneish M-Score | -0.93 | |||||
WACC vs ROIC |
Growth Rank
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 59.3 | |||||
3-Year EBITDA Growth Rate | 23.7 | |||||
3-Year Book Growth Rate | 89.3 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 36.72 | |||||
9-Day RSI | 38.33 | |||||
14-Day RSI | 43.6 | |||||
6-1 Month Momentum % | 24.94 | |||||
12-1 Month Momentum % | 20.91 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 3.75 | |||||
Quick Ratio | 2.6 | |||||
Cash Ratio | 1.06 | |||||
Days Inventory | 99.16 | |||||
Days Sales Outstanding | 61.86 | |||||
Days Payable | 71.67 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Forward Dividend Yield % | 0.74 |
Profitability Rank
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 43.22 | |||||
Operating Margin % | 18.29 | |||||
Net Margin % | -0.93 | |||||
FCF Margin % | -13.3 | |||||
ROE % | -1.3 | |||||
ROA % | -0.98 | |||||
ROIC % | -7.31 | |||||
3-Year ROIIC % | 2.89 | |||||
ROC (Joel Greenblatt) % | 14.3 | |||||
ROCE % | 9.71 | |||||
Years of Profitability over Past 10-Year | 6 |
GF Value Rank
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 2.85 | |||||
PB Ratio | 2.76 | |||||
Price-to-Tangible-Book | 2.76 | |||||
EV-to-EBIT | 35.18 | |||||
EV-to-EBITDA | 23.48 | |||||
EV-to-Revenue | 2.67 | |||||
EV-to-FCF | -20.09 | |||||
Price-to-Net-Current-Asset-Value | 6.09 | |||||
Earnings Yield (Greenblatt) % | 2.84 | |||||
FCF Yield % | -4.67 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
MEDITERA TIBBI MALZEME SANAYI VE TICARET AS Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil ₺) | 1,662.771 | ||
EPS (TTM) (₺) | -0.13 | ||
Beta | 0 | ||
Volatility % | 50.46 | ||
14-Day RSI | 43.6 | ||
14-Day ATR (₺) | 2.006789 | ||
20-Day SMA (₺) | 41.694 | ||
12-1 Month Momentum % | 20.91 | ||
52-Week Range (₺) | 24.34 - 49.96 | ||
Shares Outstanding (Mil) | 119 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 4 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
MEDITERA TIBBI MALZEME SANAYI VE TICARET AS Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
MEDITERA TIBBI MALZEME SANAYI VE TICARET AS Stock Events
Event | Date | Price(₺) | ||
---|---|---|---|---|
No Event Data |
MEDITERA TIBBI MALZEME SANAYI VE TICARET AS Frequently Asked Questions
What is MEDITERA TIBBI MALZEME SANAYI VE TICARET AS(IST:MEDTR)'s stock price today?
When is next earnings date of MEDITERA TIBBI MALZEME SANAYI VE TICARET AS(IST:MEDTR)?
Does MEDITERA TIBBI MALZEME SANAYI VE TICARET AS(IST:MEDTR) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |